Primagen Overview

  • Founded
  • 2001
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 2

Primagen General Information


Developer of molecular diagnostic products designed to monitor certain forms of cancer. The company's products offer molecular tests that have high, individualized predictive value and improve the quality of life for patients suffering from life-threatening diseases like AIDS, cancer and retinal disorders, enabling patients to avail treatment for cancer in an affordable manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • Meibergdreef 59
  • 1105 Amsterdam
  • Netherlands
+31 020 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Primagen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC Completed Startup
To view Primagen’s complete valuation and funding history, request access »

Primagen Executive Team (3)

Name Title Board Seat Contact Info
Tim Dike Chief Executive Officer
You’re viewing 1 of 3 executive team members. Get the full list »

Primagen Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MedSciences Capital Venture Capital Minority 000 0000 000000 0
UvA Ventures Holding Accelerator/Incubator Minority 000 0000 000000 0
To view Primagen’s complete investors history, request access »